MedPath

â??A STUDY TO COMPARE BETWEEN NALBUPHINE AND BUTORPHANOL AS ADJUVANTS TO ISOBARIC ROPIVACAINE WHEN INJECTED INTO THE SUB ARACHNOID SPACE IN ELECTIVE LOWER LIMB ORTHOPEDIC SURGERIESâ??

Not Applicable
Registration Number
CTRI/2022/03/041268
Lead Sponsor
Dr Sapna N Goud
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ASA grade I or II patients

BMI less than 25

Exclusion Criteria

1.Patients with known allergies to the study drugs.

2. Patients contraindicated for spinal anaesthesia

3. Patients posted for emergency procedures.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To compare the duration of analgesia and post operative analgesic effects of the drugs under study. <br/ ><br>2. To compare the sensory and motor blockade and the recovery with the drugs under study. <br/ ><br>3. To study the adverse effects of the drugs under studyTimepoint: At 5,10,15,20,25,30,35,40,45,50,55,60 minutes of drug injection <br/ ><br>After post operatives every 2 hours up to 48 hours
Secondary Outcome Measures
NameTimeMethod
To Study any Adverse effects of Drugs in Post-Operative PeriodTimepoint: From the time of Injection to 24Hours of time
© Copyright 2025. All Rights Reserved by MedPath